Cancer Therapeutics

OSL’s Pancreatic Cancer Treatment Approved for Sale in Europe

Next Investors Archived May 05, 2020

OncoSil Medical (ASX:OSL) has received CE Mark approval to market and sell its breakthrough implantable radiotherapy treatment for pancreatic cancer in the EU and UK.

PharmAust’s Epichem produces first batch of chemistry grade hand sanitiser

Finfeed Archived Apr 20, 2020

PharmAust Ltd’s (ASX: PAA) wholly owned subsidiary Epichem has produced its first batch of chemistry grade hand sanitiser.